메뉴 건너뛰기




Volumn 10, Issue 18 I, 2004, Pages 6029-6038

Molecular prediction of response to 5-fluorouracil and interferon-α combination chemotherapy in advanced hepatocellular carcinoma

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FLUOROURACIL;

EID: 4644292945     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0243     Document Type: Article
Times cited : (52)

References (44)
  • 1
    • 0028053523 scopus 로고
    • Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: Intra-arterial iodine-131-iodized oil versus medical support
    • Raoul JL, Guyader D, Bretagne JF, et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 1994;35:1782-7.
    • (1994) J Nucl Med , vol.35 , pp. 1782-1787
    • Raoul, J.L.1    Guyader, D.2    Bretagne, J.F.3
  • 2
    • 15644382890 scopus 로고    scopus 로고
    • The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study
    • Lee HS, Kim JS, Choi IJ, et al. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer (Phila) 1997;79:2087-94.
    • (1997) Cancer (Phila) , vol.79 , pp. 2087-2094
    • Lee, H.S.1    Kim, J.S.2    Choi, I.J.3
  • 3
    • 0029952414 scopus 로고    scopus 로고
    • Implications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein
    • Tanaka A, Morimoto T, Yamaoka Y. Implications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein. Hepatogastroenterology 1996;43:637-43.
    • (1996) Hepatogastroenterology , vol.43 , pp. 637-643
    • Tanaka, A.1    Morimoto, T.2    Yamaoka, Y.3
  • 4
    • 0031911767 scopus 로고    scopus 로고
    • Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: Proposal as a standard therapy
    • Ikai I, Yamaoka Y, Yamamoto Y, et al. Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg 1998;227:433-9.
    • (1998) Ann Surg , vol.227 , pp. 433-439
    • Ikai, I.1    Yamaoka, Y.2    Yamamoto, Y.3
  • 5
    • 0037080269 scopus 로고    scopus 로고
    • Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches
    • Sakon M, Nagano H, Dono K, et al. Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer (Phila) 2002;94:435-42.
    • (2002) Cancer (Phila) , vol.94 , pp. 435-442
    • Sakon, M.1    Nagano, H.2    Dono, K.3
  • 6
    • 0027433529 scopus 로고
    • Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b
    • Patt YZ, Yoffe B, Charnsangavej C, et al. Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b. Cancer (Phila) 1993;72:2574-82.
    • (1993) Cancer (Phila) , vol.72 , pp. 2574-2582
    • Patt, Y.Z.1    Yoffe, B.2    Charnsangavej, C.3
  • 7
    • 0030853192 scopus 로고    scopus 로고
    • Adaptor-tagged competitive PCR: A novel method for measuring relative gene expression
    • Kato K. Adaptor-tagged competitive PCR: a novel method for measuring relative gene expression. Nucleic Acids Res 1997;25:4694-6.
    • (1997) Nucleic Acids Res , vol.25 , pp. 4694-4696
    • Kato, K.1
  • 8
    • 0020396015 scopus 로고
    • Toxicity and response criteria of the Eastern Cooperative Oncology Group
    • Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
    • (1982) Am J Clin Oncol , vol.5 , pp. 649-655
    • Oken, M.M.1    Creech, R.H.2    Tormey, D.C.3
  • 9
    • 0033992317 scopus 로고    scopus 로고
    • Gene expression in mouse cerebellum during its development
    • Matoba R, Kato K, Saito S, et al. Gene expression in mouse cerebellum during its development. Gene (Amst) 2000;241:125-31.
    • (2000) Gene (Amst) , vol.241 , pp. 125-131
    • Matoba, R.1    Kato, K.2    Saito, S.3
  • 10
    • 0034005593 scopus 로고    scopus 로고
    • Correlation between gene functions and developmental expression patterns in the mouse cerebellum
    • Matoba R, Kato K, Kurooka C, et al. Correlation between gene functions and developmental expression patterns in the mouse cerebellum. Eur J Neurosci 2000;12:1357-71.
    • (2000) Eur J Neurosci , vol.12 , pp. 1357-1371
    • Matoba, R.1    Kato, K.2    Kurooka, C.3
  • 11
    • 0346874203 scopus 로고    scopus 로고
    • Molecular features of non-B, non-C hepatocellular carcinoma: A PCR-array gene expression profiling study
    • Kurokawa Y, Matoba R, Takemasa I, et al. Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study. J Hepatol 2003;39:1007-15.
    • (2003) J Hepatol , vol.39 , pp. 1007-1015
    • Kurokawa, Y.1    Matoba, R.2    Takemasa, I.3
  • 12
    • 11144356800 scopus 로고    scopus 로고
    • PCR-array gene expression profiling of hepatocellular carcinoma
    • Kurokawa Y, Matoba R, Nakamori S, et al. PCR-array gene expression profiling of hepatocellular carcinoma. J Exp Clin Cancer Res 2004;23:135-41.
    • (2004) J Exp Clin Cancer Res , vol.23 , pp. 135-141
    • Kurokawa, Y.1    Matoba, R.2    Nakamori, S.3
  • 13
    • 4444286417 scopus 로고    scopus 로고
    • Molecular-based prediction of early recurrence in hepatocellular carcinoma
    • Kurokawa Y, Matoba R, Takemasa I, et al. Molecular-based prediction of early recurrence in hepatocellular carcinoma. J Hepatol 2004;41:284-91.
    • (2004) J Hepatol , vol.41 , pp. 284-291
    • Kurokawa, Y.1    Matoba, R.2    Takemasa, I.3
  • 14
    • 0037081785 scopus 로고    scopus 로고
    • Molecular classification of primary breast tumors possessing distinct prognostic properties
    • Iwao K, Matoba R, Ueno N, et al. Molecular classification of primary breast tumors possessing distinct prognostic properties. Hum Mol Genet 2002;11:199-206.
    • (2002) Hum Mol Genet , vol.11 , pp. 199-206
    • Iwao, K.1    Matoba, R.2    Ueno, N.3
  • 15
    • 4644364404 scopus 로고    scopus 로고
    • Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data
    • Muro S, Takemasa I, Oba S, et al. Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data. Genome Biol http://genome-biology.com/2003/4/3/ R21.
    • Genome Biol
    • Muro, S.1    Takemasa, I.2    Oba, S.3
  • 16
    • 0033569406 scopus 로고    scopus 로고
    • Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
    • Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (Wash DC) 1999;286:531-7.
    • (1999) Science (Wash DC) , vol.286 , pp. 531-537
    • Golub, T.R.1    Slonim, D.K.2    Tamayo, P.3
  • 17
    • 0034794796 scopus 로고    scopus 로고
    • Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease
    • MacDonald TJ, Brown KM, LaFleur B, et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 2001;29:143-52.
    • (2001) Nat Genet , vol.29 , pp. 143-152
    • MacDonald, T.J.1    Brown, K.M.2    LaFleur, B.3
  • 18
    • 0037165140 scopus 로고    scopus 로고
    • Prediction of central nervous system embryonal tumor outcome based on gene expression
    • Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous system embryonal tumor outcome based on gene expression. Nature (Lond) 2002;415:436-42.
    • (2002) Nature (Lond) , vol.415 , pp. 436-442
    • Pomeroy, S.L.1    Tamayo, P.2    Gaasenbeek, M.3
  • 19
    • 18544375333 scopus 로고    scopus 로고
    • MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
    • Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002;30:41-7.
    • (2002) Nat Genet , vol.30 , pp. 41-47
    • Armstrong, S.A.1    Staunton, J.E.2    Silverman, L.B.3
  • 20
    • 0037226593 scopus 로고    scopus 로고
    • A molecular signature of metastasis in primary solid tumors
    • Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
    • (2003) Nat Genet , vol.33 , pp. 49-54
    • Ramaswamy, S.1    Ross, K.N.2    Lander, E.S.3    Golub, T.R.4
  • 21
    • 0042125511 scopus 로고    scopus 로고
    • Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
    • Chang JC, Wooten EC, Tsimelzon A, et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 2003;362:362-9.
    • (2003) Lancet , vol.362 , pp. 362-369
    • Chang, J.C.1    Wooten, E.C.2    Tsimelzon, A.3
  • 22
    • 0035942271 scopus 로고    scopus 로고
    • Significance analysis of microarrays applied to the ionizing radiation response
    • Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-21.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 5116-5121
    • Tusher, V.G.1    Tibshirani, R.2    Chu, G.3
  • 23
    • 0042424602 scopus 로고    scopus 로고
    • Statistical significance for genomewide studies
    • Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003;100:9440-5.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 9440-9445
    • Storey, J.D.1    Tibshirani, R.2
  • 24
    • 17544380855 scopus 로고    scopus 로고
    • Clinical significance of hepatic resection in hepatocellular carcinoma
    • Sakon M, Umeshita K, Nagano H, et al. Clinical significance of hepatic resection in hepatocellular carcinoma. Arch Surg 2000;135:1456-9.
    • (2000) Arch Surg , vol.135 , pp. 1456-1459
    • Sakon, M.1    Umeshita, K.2    Nagano, H.3
  • 25
    • 0036096420 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: Diagnosis and treatment
    • Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002;122:1609-19.
    • (2002) Gastroenterology , vol.122 , pp. 1609-1619
    • Befeler, A.S.1    Di Bisceglie, A.M.2
  • 26
    • 0028965102 scopus 로고
    • Hepatic resection for hepatocellular carcinoma. An audit of 343 patients
    • Lai EC, Fan ST, Lo CM, et al. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 1995;221:291-8.
    • (1995) Ann Surg , vol.221 , pp. 291-298
    • Lai, E.C.1    Fan, S.T.2    Lo, C.M.3
  • 27
    • 0034941503 scopus 로고    scopus 로고
    • Improving survival results after resection of hepatocellular carcinoma: A prospective study of 377 patients over 10 years
    • Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001;234:63-70.
    • (2001) Ann Surg , vol.234 , pp. 63-70
    • Poon, R.T.1    Fan, S.T.2    Lo, C.M.3
  • 28
    • 0035876465 scopus 로고    scopus 로고
    • Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: Metaanalysis of three randomized controlled trials
    • Ono T, Yamanoi A, Nazmy EI, et al. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials. Cancer (Phila) 2001;91:2378-85.
    • (2001) Cancer (Phila) , vol.91 , pp. 2378-2385
    • Ono, T.1    Yamanoi, A.2    Nazmy, E.I.3
  • 29
    • 18544365698 scopus 로고    scopus 로고
    • Gene-expression profiles predict survival of patients with lung adenocarcinoma
    • Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002;8:816-24.
    • (2002) Nat Med , vol.8 , pp. 816-824
    • Beer, D.G.1    Kardia, S.L.2    Huang, C.C.3
  • 30
    • 0037142053 scopus 로고    scopus 로고
    • The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
    • Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-47.
    • (2002) N Engl J Med , vol.346 , pp. 1937-1947
    • Rosenwald, A.1    Wright, G.2    Chan, W.C.3
  • 31
    • 0037137519 scopus 로고    scopus 로고
    • A gene-expression signature as a predictor of survival in breast cancer
    • van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
    • (2002) N Engl J Med , vol.347 , pp. 1999-2009
    • Van De Vijver, M.J.1    He, Y.D.2    Van't Veer, L.J.3
  • 32
    • 0037177855 scopus 로고    scopus 로고
    • Transcript abundance in yeast varies over six orders of magnitude
    • Holland MJ. Transcript abundance in yeast varies over six orders of magnitude. J Biol Chem 2002;277:14363-6.
    • (2002) J Biol Chem , vol.277 , pp. 14363-14366
    • Holland, M.J.1
  • 33
    • 0032905998 scopus 로고    scopus 로고
    • Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin
    • Rowinsky EK, Jiroutek M, Bonomi P, Johnson D, Baker SD. Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin. Clin Cancer Res 1999;5:767-74.
    • (1999) Clin Cancer Res , vol.5 , pp. 767-774
    • Rowinsky, E.K.1    Jiroutek, M.2    Bonomi, P.3    Johnson, D.4    Baker, S.D.5
  • 34
    • 0037990003 scopus 로고    scopus 로고
    • Methylenetetra-hydrofolate reductase polymorphism in advanced colorectal cancer: A novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy
    • Cohen V, Panel-Raymond V, Sabbaghian N, et al. Methylenetetra-hydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy. Clin Cancer Res 2003;9:1611-5.
    • (2003) Clin Cancer Res , vol.9 , pp. 1611-1615
    • Cohen, V.1    Panel-Raymond, V.2    Sabbaghian, N.3
  • 35
    • 0033796587 scopus 로고    scopus 로고
    • A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs
    • Eichhorst ST, Muller M, Li-Weber M, et al. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol Cell Biol 2000;20:7826-37.
    • (2000) Mol Cell Biol , vol.20 , pp. 7826-7837
    • Eichhorst, S.T.1    Muller, M.2    Li-Weber, M.3
  • 36
    • 0036300989 scopus 로고    scopus 로고
    • The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer
    • Sjostrom J, Blomqvist C, von Boguslawski K, et al. The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer. Clin Cancer Res 2002;8:811-6.
    • (2002) Clin Cancer Res , vol.8 , pp. 811-816
    • Sjostrom, J.1    Blomqvist, C.2    Von Boguslawski, K.3
  • 37
    • 0034971588 scopus 로고    scopus 로고
    • Reduction in matrix metalloproteinase production by tendon and synovial fibroblasts after a single exposure to 5-fluorouracil
    • Ragoowansi R, Khan U, Brown RA, McGrouther DA. Reduction in matrix metalloproteinase production by tendon and synovial fibroblasts after a single exposure to 5-fluorouracil. Br J Plast Surg 2001;54:283-7.
    • (2001) Br J Plast Surg , vol.54 , pp. 283-287
    • Ragoowansi, R.1    Khan, U.2    Brown, R.A.3    McGrouther, D.A.4
  • 38
    • 0034655105 scopus 로고    scopus 로고
    • 19F magnetic resonance spectroscopy in vivo predict response of murine RIF-1 tumors to 5-fluorouracil
    • 19F magnetic resonance spectroscopy in vivo predict response of murine RIF-1 tumors to 5-fluorouracil. Cancer Res 2000;60:2122-7.
    • (2000) Cancer Res , vol.60 , pp. 2122-2127
    • McSheehy, P.M.1    Leach, M.O.2    Judson, I.R.3    Griffiths, J.R.4
  • 39
    • 0032530089 scopus 로고    scopus 로고
    • p59OASL, a 2′-5′ oligoadenylate synthetase like protein: A novel human gene related to the 2′-5′ oligoadenylate synthetase family
    • Hartmann R, Olsen HS, Widder S, Jorgensen R, Justesen J. p59OASL, a 2′-5′ oligoadenylate synthetase like protein: a novel human gene related to the 2′-5′ oligoadenylate synthetase family. Nucleic Acids Res 1998;26:4121-8.
    • (1998) Nucleic Acids Res , vol.26 , pp. 4121-4128
    • Hartmann, R.1    Olsen, H.S.2    Widder, S.3    Jorgensen, R.4    Justesen, J.5
  • 40
    • 0038239253 scopus 로고    scopus 로고
    • Characterization of the 2′-5′-oligoadenylate synthetase ubiquitin-like family
    • Eskildsen S, Justesen J, Schierup MH, Hartmann R. Characterization of the 2′-5′-oligoadenylate synthetase ubiquitin-like family. Nucleic Acids Res 2003;31:3166-73.
    • (2003) Nucleic Acids Res , vol.31 , pp. 3166-3173
    • Eskildsen, S.1    Justesen, J.2    Schierup, M.H.3    Hartmann, R.4
  • 41
    • 0037790592 scopus 로고    scopus 로고
    • Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis
    • Chawla-Sarkar M, Lindner DJ, Liu YF, et al. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003;8:237-49.
    • (2003) Apoptosis , vol.8 , pp. 237-249
    • Chawla-Sarkar, M.1    Lindner, D.J.2    Liu, Y.F.3
  • 42
    • 0025360452 scopus 로고
    • Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: Correlation with the expression of a kidney-associated differentiation glycoprotein
    • Nanus DM, Pfeffer LM, Bander NH, Bahri S, Albino AP. Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein. Cancer Res 1990;50:4190-4.
    • (1990) Cancer Res , vol.50 , pp. 4190-4194
    • Nanus, D.M.1    Pfeffer, L.M.2    Bander, N.H.3    Bahri, S.4    Albino, A.P.5
  • 43
    • 0025228386 scopus 로고
    • Effect of calmodulin antagonists on the interferon system: Induction and action of interferons
    • Lin HY, Davis PJ, Davis FB, Chadha KC, Thacore HR. Effect of calmodulin antagonists on the interferon system: induction and action of interferons. J Interferon Res 1990;10:39-46.
    • (1990) J Interferon Res , vol.10 , pp. 39-46
    • Lin, H.Y.1    Davis, P.J.2    Davis, F.B.3    Chadha, K.C.4    Thacore, H.R.5
  • 44
    • 0021824119 scopus 로고
    • Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: A pilot study
    • Sachs E, Di Bisceglie AM, Dusheiko GM, et al. Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study. Br J Cancer 1985;52:105-9.
    • (1985) Br J Cancer , vol.52 , pp. 105-109
    • Sachs, E.1    Di Bisceglie, A.M.2    Dusheiko, G.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.